弱毒ウイルス、弱毒性ウイルス

WordNet

a harmful or corrupting agency; "bigotry is a virus that must not be allowed to spread"; "the virus of jealousy is latent in everyone"
(virology) ultramicroscopic infectious agent that replicates itself only within cells of living hosts; many are pathogenic; a piece of nucleic acid (DNA or RNA) wrapped in a thin coat of protein
a software program capable of reproducing itself and usually capable of causing great harm to files or other programs on the same computer; "a true virus cannot spread to another computer without human assistance" (同)computer virus
become weaker, in strength, value, or magnitude
reduced in strength; "the faded tones of an old recording" (同)attenuated, faded, weakened
of an electrical signal; reduced in amplitude with little or no distortion

PrepTutorEJDIC

ビールス,ろ過性病原体
〈固体など〉'を'細くする;〈体など〉'を'やせさせる / 〈力・価値など〉'を'減じる,弱める

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2016/05/31 16:53:20」(JST)

wiki en

An attenuated vaccine is a vaccine created by reducing the virulence of a pathogen, but still keeping it viable (or "live").^[1] Attenuation takes an infectious agent and alters it so that it becomes harmless or less virulent. These vaccines contrast to those produced by "killing" the virus (inactivated vaccine).

Examples

Examples of "live" (example attenuated) vaccines include:

Viral: measles vaccine, mumps vaccine, rubella vaccine, Live attenuated influenza vaccine (the seasonal flu nasal spray and the 2009 H1N1 flu nasal spray), chicken pox vaccine, oral polio vaccine (Sabin), rotavirus vaccine, and yellow fever vaccine.^[2] Rabies vaccines are now available in two different attenuated forms, one for use in humans, and one for animal usage.
Bacterial: BCG vaccine,^[2] typhoid vaccine^[3] and epidemic typhus vaccine.

Development

Viruses may be attenuated via passage of the virus through a foreign host, such as:

Tissue culture
Embryonated eggs
Live animals

The initial virus population is applied to a foreign host. One or more of these will possess a mutation that enables it to infect the new host. These mutations will spread, as the mutations allow the virus to grow well in the new host; the result is a population that is significantly different from the initial population, and thus will not grow well in the original host when it is re-introduced (hence is "attenuated"). This process is known as "passage" in which the virus becomes so well adapted to the foreign host that it is no longer harmful to the vaccinated subject. This makes it easier for the host's immune system to eliminate the agent and create the immunological memory cells which will likely protect the patient if they are infected with a similar version of the virus in "the wild".

Administration

In an attenuated vaccine, live virus particles with very low virulence are administered. They will reproduce, but very slowly. Since they do reproduce and continue to present antigen beyond the initial vaccination, boosters are required less often. These vaccines are produced by growing the virus in tissue cultures that will select for less virulent strains, or by mutagenesis or targeted deletions in genes required for virulence. There is a small risk of reversion to virulence; this risk is smaller in vaccines with deletions. Attenuated vaccines also cannot be used by immunocompromised individuals.

Advantages

Activates all phases of the immune system (for instance IgA local antibodies are produced)^{[citation needed]}
Provides more durable immunity; boosters are required less frequently^{[citation needed]}
Low cost^{[citation needed]}
Quick immunity^{[citation needed]}
Easy to transport/administer (for instance OPV for polio can be taken orally, rather than requiring a sterile injection by a trained healthworker, as the inactivated form IPV does)^{[citation needed]}
Vaccines have strong beneficial non-specific effects. That is effects which go beyond the specific protective effects against the targeted diseases.^[4]

Disadvantages

Secondary mutation can cause a reversion to virulence.^[5]
Can cause severe complications in immunocompromised patients.^[6]
Can be difficult to transport due to requirement to maintain conditions (e.g. temperature)

References

^ Badgett MR, Auer A, Carmichael LE, Parrish CR, Bull JJ (October 2002). "Evolutionary dynamics of viral attenuation". J. Virol. 76 (20): 10524–9. doi:10.1128/JVI.76.20.10524-10529.2002. PMC 136581. PMID 12239331.
^ ^a ^b "Immunization". Archived from the original on 7 March 2009. Retrieved 2009-03-10.
^ Levine, Myron M.; Ferreccio, Catterine; Black, Robert E.; Lagos, Rosanna; Martin, Oriana San; Blackwelder, William C. (July 15, 2007). "Ty21a Live Oral Typhoid Vaccine and Prevention of Paratyphoid Fever Caused by Salmonella enterica Serovar Paratyphi B". Clinical Infectious Diseases 45 (Supplement 1): S24–S28. doi:10.1086/518141. ISSN 1058-4838. PMID 17582564.
^ Benn, Christine S.; Netea, Mihai G.; Selin, Liisa K.; Aaby, Peter (September 2013). "A small jab – a big effect: nonspecific immunomodulation by vaccines". Trends in Immunology (Elsevier) 34 (9): 431–439. doi:10.1016/j.it.2013.04.004. PMID 23680130.
^ Shimizu H, Thorley B, Paladin FJ; et al. (December 2004). "Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001". J. Virol. 78 (24): 13512–21. doi:10.1128/JVI.78.24.13512-13521.2004. PMC 533948. PMID 15564462.
^ Kroger, Andrew T.; Ciro V. Sumaya; Larry K. Pickering; William L. Atkinson (2011-01-28). "General Recommendations on Immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP)". Morbidity and Mortality Weekly Report (MMWR) (Centers for Disease Control and Prevention). Retrieved 2011-03-11.

External links

Global Polio Eradication Initiative: Advantages and Disadvantages of Vaccine Types
CDC H1N1 Flu / 2009 H1N1 Nasal Spray Vaccine Q&A at the website of the US Centers for Disease Control and Prevention

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. ウイルス誘発性の喘鳴および喘息：概要 virus induced wheezing and asthma an overview
2. 小児における季節性インフルエンザ：ワクチン接種による予防 seasonal influenza in children prevention with vaccines
3. 小児および思春期におけるB型肝炎ウイルス感染の概要 overview of hepatitis b virus infection in children and adolescents
4. 関節炎の原因となる特定のウイルス specific viruses that cause arthritis
5. 水痘帯状疱疹ウイルス感染予防のためのワクチン接種：水痘 vaccination for the prevention of varicella zoster virus infection chickenpox

English Journal

Oncolytic cancer therapy with a vaccinia virus strain.

Deng L1, Fan J1, Ding Y1, Zhang J1, Zhou B1, Zhang Y1, Huang B1, Hu Z2.
Oncology reports.Oncol Rep.2019 Jan;41(1):686-692. doi: 10.3892/or.2018.6801. Epub 2018 Oct 16.
PMID 30365140

Importin α5 negatively regulates importin β1-mediated nuclear import of Newcastle disease virus matrix protein and viral replication and pathogenicity in chicken fibroblasts.

Duan Z1,2, Xu H3, Ji X1,2, Zhao J1,2, Xu H1,2, Hu Y2, Deng S2, Hu S3, Liu X3.
Virulence.Virulence.2018 Dec 31;9(1):783-803. doi: 10.1080/21505594.2018.1449507.
PMID 29532715

Developing Vaccines Against Foot-and-Mouth Disease: a Biotechnological Approach.

Shahriari A1, Habibi-Pirkoohi M2,2.
Archives of Razi Institute.Arch Razi Inst.2018 Dec;73(1):1-10. doi: 10.22092/ARI.2018.114054. Epub 2017 May 15.
PMID 30256033

Japanese Journal

ムンプスウイルス感染症が先行し視神経炎で発症した抗myelin oligodendrocyte glycoprotein (MOG) 抗体陽性関連脱髄疾患の1例

水沼真也,川本大樹,津田祐子,田村彰,南弘一,鈴木啓之,高橋利幸
脳と発達 51(3), 206-208, 2019
… 右視力は10cm手動弁まで低下しており, 頭部MRIのT2強調画像とfluid attenuated inversion recovery (FLAIR) で右視神経の腫大, 両側大脳皮質下白質に高信号病変を認めた. …
NAID 130007642949

日本獸醫學雜誌(The Japanese Journal of Veterinary Science)

SANTOS Romeu Moreira dos,FERNANDO Filipe Santos,MONTASSIER Maria de Fátima Silva,SILVA Ketherson Rodrigues,LOPES Priscila Diniz,PAVANI Caren,BORZI Mariana Monezi,OKINO Cintia Hiromi,MONTASSIER Helio José
Ｔｈｅ　Ｊｏｕｒｎａｌ　ｏｆ　Ｖｅｔｅｒｉｎａｒｙ　Ｍｅｄｉｃａｌ　Ｓｃｉｅｎｃｅ 81(4), 612-619, 2019
… <p>In this study, we evaluated antibody and cell-mediated immune (CMI) responses in the mucosal and systemic compartments and protection against challenge with a nephropathogenic Brazilian (BR-I) strain of infectious bronchitis virus (IBV) in chickens submitted to a vaccination regime comprising a priming dose of heterologous live attenuated Massachusetts vaccine followed by a booster dose of an experimental homologous inactivated vaccine two weeks later. …
NAID 130007638720

Memory immune responses and protection of chickens against a nephropathogenic infectious bronchitis virus strain by combining live heterologous and inactivated homologous vaccines

SANTOS Romeu Moreira dos,FERNANDO Filipe Santos,MONTASSIER Maria de Fátima Silva,SILVA Ketherson Rodrigues,LOPES Priscila Diniz,PAVANI Caren,BORZI Mariana Monezi,OKINO Cintia Hiromi,MONTASSIER Helio José
Ｔｈｅ　Ｊｏｕｒｎａｌ　ｏｆ　Ｖｅｔｅｒｉｎａｒｙ　Ｍｅｄｉｃａｌ　Ｓｃｉｅｎｃｅ, 2019
… <p>In this study, we evaluated antibody and cell-mediated immune (CMI) responses in the mucosal and systemic compartments and protection against challenge with a nephropathogenic Brazilian (BR-I) strain of infectious bronchitis virus (IBV) in chickens submitted to a vaccination regime comprising a priming dose of heterologous live attenuated Massachusetts vaccine followed by a booster dose of an experimental homologous inactivated vaccine two weeks later. …
NAID 130007610699